Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence

Journal of Nuclear Medicine

Volumn 45, Issue 10, 2004, Pages 1669-1676

  Ng, Shu Hang ^a   Tung Chieh, Joseph Chang ^a   Chan, Sheng Chieh ^a   Ko, Sheung Fat ^a   Wang, Hung Ming ^a   Liao, Chun Ta ^a   Chang, Yu Chen ^a   Lin, Wuu Jyh ^b   Fu, Ying Kai ^b   Yen, Tzu Chen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

Author keywords

18F FDG PET; MRI; Nasopharyngeal carcinoma; Tumor recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; CARCINOMA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METASTASIS; METHODOLOGY; MIDDLE AGED; NASOPHARYNX TUMOR; REPRODUCIBILITY; SCINTISCANNING; TUMOR RECURRENCE; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 16544387075     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Simon MJ, Shanmugaratnam K, eds. The biology of nasopharyngeal carcinoma. In: UICC Technical Report Series. Geneva, Switzerland: International Union Against Cancer; 1982:17.
2. Huang DP. Epidemiology and aetiology. In: Hasselt CAV, Gibb AG, eds. Nasopharyngeal Carcinoma. Hong Kong, China: The Chinese University Press; 1991;23.
3. Parkin DM, Whelan DL, Ferley J. Cancer Incidence in Five Continents. Vol 7. Lyon France: International Agency for Research on Cancer; 1997. Publication 143.
4. Easton JE, Levin PH, Hyarns VJ. Nasopharyngeal carcinoma in the United States: a pathological study of 177 US and 30 foreign cases. Arch Otolaryngol. 1980;106:88-91.
5. Orecchia R, Airoldi M, Sola B, et al. Results of chemotherapy plus external re-irradiation in the treatment of locally advanced recurrences of nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol. 1992;28B:109-111.
6. Dimery IW, Peter LJ, Goepfert H, et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol. 1993;11:1919-1928.
7. Lell M, Baum U, Greess H, et al. Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol. 2000;33:239-247.
8. Ng SH, Liu HM, Ko SF, et al. Posttreatment imaging of the nasopharynx. Eur J Radiol. 2002;44:82-95.
9. Becker M, Schroth G, Zbaren P. Long-term changes induced by high-dose irradiation of the head and neck region: imaging findings. Radiographics. 1997;17:5-26.
10. Chong VFH, Fan YF. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology. 1997;202:463-470.
11. Olmi P, Fallai C, Colagradne S, Giannardi G. Staging and follow up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol Phys. 1995;32:795-800.
12. Gong QY, Zheng GL, Zhu HY. MRI differentiation of recurrent nasopharyngeal carcinoma from postradiation fibrosis. Comput Med Imaging Graph. 1991;15:423-429.
13. Fujii M, Kanzaki J. The role of MRI for the diagnosis of recurrence of nasopharyngeal cancer. Auris Nasus Larynx. 1994;21:32-37.
14. Ng SH, Chang TC, Ko SF, Wan YL, Tang LM, Chen WC. MRI in recurrent nasopharyngeal carcinoma. Neuroradiology. 1999;41:855-862.
15. Ng SH, Wan YL, Ko SF, Chang JT. MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapy. J Magn Reson Imaging. 1998;8:327-336.
16. Ng SH, Chong VFH, Ko SF, Mukherji SK. Magnetic resonance imaging of nasopharyngeal carcinoma. Top Magn Reson Imaging. 1999;10:290-303.
17. Wahl RL. Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. J Nucl Med. 1996;376:1038-1041.
18. Lapela M, Greneman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology. 1995;197:205-211.
19. Fischbein NJ, Assar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluoro-deoxyglucose in detecting residual/recurrent squamous cell carcinoma of head and neck. AJNR. 1998;19:1189-1196.
20. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro- D-glucose PET and MRI diagnoses. Radiology. 1996;200:135-141.
21. Wong WL, Chevretton EB, McCurk M, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol. 1997;22:209-214.
22. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope. 1990;109:880-885.
23. 18F-2-fluoro- 2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol. 2000;109:1130-1134.
24. Kao CH, ChangLai SP, Chieng PU, Yen RF, Yen TC. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol. 1998;16:3550-3555.
25. 18F-2-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy. Cancer. 2001;92:434-439.
26. Kao CH, Shiau YC, Shen YY, Yen RF. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m- methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Cancer. 2002;94:1981-1986.
27. Tsai MH, Shiau YC, Kao CH, Shen YY, Lin CC, Lee CC. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate MRI findings after radiotherapy. J Cancer Res Clin Oncol. 2002;128:279-282.
28. Yen RF, Hung RL, Pan MH, et al. FDG PET in detecting residual/recurrent NPC and comparison with MRI. Cancer. 2003;98:283-287.
29. Yen TC, Ng KK, Ma SY, et al. Value of dual-phase 2-fluoro-2-deoxy-D- glucose positron emission tomography in cervical cancer. J Clin Oncol. 2003;21:3651-3658.
30. Sham JST, Wei WI, Kwan WH, Chan CW, Kwong WK, Choy D. Nasopharyngeal carcinoma: pattern of tumor regression after radiotherapy. Cancer. 1990;65:216-220.
31. Chang JT, See LC, Liao CT, et al. Locally recurrent nasopharyngeal carcinoma. Radiother Oncol 2000;54:135-142.